Wen‐Lin Luo

1.9k citations

34 papers · 1.2k indexed · h-index 14

Impact in

Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
Cognitive Neuroscience top 5%
- Functional Brain Connectivity Studies
- Neural dynamics and brain function

Papers in

Transplantation 2
Pharmacology 5
- Pharmacogenetics and Drug Metabolism 5

Co-authors: Thomas E. Nichols Torben E. Lund Kristoffer H. Madsen Karam Sidaros John A. Wagner Gary Herman Arthur Bergman Michael J. Davies
Journals: NeuroImage (3 papers)The Journal of Clinical Pharmacology (3 papers)Pharmaceutical Statistics (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Wen‐Lin Luo

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Wen‐Lin Luo

Since Specialization

Citations

This map shows the geographic impact of Wen‐Lin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Lin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Lin Luo more than expected).

Fields of papers citing papers by Wen‐Lin Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Lin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Lin Luo. The network helps show where Wen‐Lin Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Wen‐Lin Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wen‐Lin Luo Line = papers co-authored together Wen‐Lin Luo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study Arthritis & Rheumatology ·Thomas Dörner, Simon Bowman, Robert I. Fox, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops, Robert J. Moots, G. Junge, A. C. Amaral, Monika Sopala, Alexandre Avraméas, Wen‐Lin Luo, Wolfgang Hueber	2024	3
2	Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study The Lancet ·Benjamin A. Fisher, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Hendrika Bootsma, Wan‐Fai Ng, Paul Van Daele, Stephanie Finzel, Ghaith Noaiseh, Khushbu Yagnik, Josef Hermann, Sara S. McCoy, Esen K. Akpek, Arthur Bookman, Monika Sopala, Rémi Desmoulière, Wen‐Lin Luo, Ernesto J. Maldonado-Ojeda, Wolfgang Hueber, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	13
3	Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study Pharmaceutical Statistics ·Björn Holzhauer, Lisa V. Hampson, John Paul Gosling, Björn Bornkamp, Joseph M. Kahn, Sen Nc, Wen‐Lin Luo, Caterina Brindicci, David Lawrence, Thomas F. Gordan, Anthony O’Hagan	2022	5
4	Improving the assessment of the probability of success in late stage drug development Pharmaceutical Statistics ·Lisa V. Hampson, Björn Bornkamp, Björn Holzhauer, Joseph M. Kahn, Sen Nc, Wen‐Lin Luo, Giovanni Della Cioppa, Kelvin Stott, Thomas F. Gordan	2021	12
5	Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial The Lancet ·Simon Bowman, Robert I. Fox, Thomas Dörner, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops, Robert J. Moots, G. Junge, A. C. Amaral, Monika Sopala, Wen‐Lin Luo, Wolfgang Hueber	2021	115
6	Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation Journal of the American Society of Nephrology ·Julio Pascual, Stefan P. Berger, Oliver Witzke, Hélio Tedesco‐Silva, Shamkant Mulgaonkar, Yasir Qazi, Steven J. Chadban, Federico Oppenheimer, Claudia Sommerer, Rainer Oberbauer, Yoshihiko Watarai, Christophe Legendre, Franco Citterio, Mitchell L. Henry, Titte R. Srinivas, Wen‐Lin Luo, Renoza Dewa Brata, Peter Bernhardt, Flavio Vincenti, (unknown)	2018	177
7	On the Use of Group Sequential Study Designs for the Test of Bioequivalence for Complicated Products Journal of Pharmaceutical Sciences ·Rajesh Krishna, Wen‐Lin Luo, Patrick Larson, Paul Fackler	2017	0
8	Evaluation of drug‐drug interaction between daclatasvir and methadone or buprenorphine/naloxone Journal of the International AIDS Society ·Τushar Garimella, 国男釜, Wen‐Lin Luo, Philip Wastall, Hamza Kandoussi, Michael DeMicco, Douglas Bruce, Carey Hwang, Richard Bertz, Marc Bifano	2014	5
9	The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin Platelets ·Pieter‐Jan de Kam, Wen‐Lin Luo, Larissa Wenning, G. Dickten, Christine McCrary Sisk, Jane Royalty, Waldemar Radziszewski, John A. Wagner, Eseng Lai	2013	3
10	Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naïve HIV-Infected Patients Antimicrobial Agents and Chemotherapy ·Matthew L. Rizk, Yaming Hang, Wen‐Lin Luo, Jing Su, Jing Zhao, Havilland Campbell, Bach‐Yen Nguyen, Peter Sklar, Joseph J. Eron, Larissa Wenning	2012	77
11	The effects of simvastatin on the pharmacokinectics of sitagliptin. PubMed ·Michael Cerra, Wen‐Lin Luo, Dong Chao-feng, Catherine Z. Matthews, Edward A. O’Neill, John A. Wagner, S. Aubrey Stoch, Matt S. Anderson	2012	8
12	The effects of laropiprant, a selective prostaglandin D₂receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin Platelets ·Aimée Dallob, Wen‐Lin Luo, Peter D. Young, G. Dickten, Amy O. Johnson‐Levonas, Jules I. Schwartz, Victor Dishy, Walter K. Kraft, Jan de Hoon, Anne Van Hecken, Inge De Lepeleire, Waldemar Radziszewski, John A. Wagner, Eseng Lai	2011	8
13	Effects of Multiple Doses of Clarithromycin on the Pharmacokinetics of Laropiprant in Healthy Subjects Cardiovascular Therapeutics ·Ying-Hong Wang, Jules I. Schwartz, Wen‐Lin Luo, Patricia Jumes, N. A. Cafarova, Larissa Wenning, John A. Wagner, Eseng Lai	2010	1
14	Single Therapeutic and Supratherapeutic Doses of Laropiprant, a Selective Prostaglandin D₂ Receptor 1 Antagonist, Do Not Prolong the QTcF Interval in Healthy Volunteers The Journal of Clinical Pharmacology ·Wen‐Lin Luo, Tami Crumley, David L. Ebel, George Atiee, Jane Royalty, Amy O. Johnson‐Levonas, John A. Wagner, Eseng Lai	2010	2
15	Laropiprant in Combination With Extended‐Release Niacin Does Not Alter Urine 11‐Dehydrothromboxane B₂, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects The Journal of Clinical Pharmacology ·Brett Lauring, Victor Dishy, Wen‐Lin Luo, Omar Laterza, R.B. Lee, Josée Côté, Yehia Salah El Din Mostafa, Patrick Larson, María J. Gutiérrez, John A. Wagner, Eseng Lai	2009	12
16	Dose‐proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase‐4 inhibitor, in healthy volunteers Biopharmaceutics & Drug Disposition ·Arthur Bergman, Goutam C. Mistry, Wen‐Lin Luo, 正則江藤, Julie A. Stone, Amy Wang, Wei Zeng, Li Chen, Stacy C. Dilzer, Kenneth C. Lasseter, Gary Herman, John A. Wagner, Rajesh Krishna	2007	14
17	Multiple‐Dose Administration of Sitagliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Does Not Alter the Single‐Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects The Journal of Clinical Pharmacology ·Goutam C. Mistry, Arthur Bergman, Wen‐Lin Luo, Caroline Cilissen, Wouter Haazen, Michael J. Davies, Keith Gottesdiener, John A. Wagner, Gary Herman	2007	42
18	Diagnosis of single‐subject and group fMRI data with SPMd Human Brain Mapping ·Hui Zhang, Wen‐Lin Luo, Thomas E. Nichols	2006	17
19	Non-white noise in fMRI: Does modelling have an impact? NeuroImage ·Torben E. Lund, Kristoffer H. Madsen, Karam Sidaros, Wen‐Lin Luo, Thomas E. Nichols	2005	338
20	Diagnosis and exploration of massively univariate neuroimaging models NeuroImage ·Wen‐Lin Luo, Thomas E. Nichols	2003	105

About Wen‐Lin Luo

Wen‐Lin Luo is a scholar working on Transplantation, Pharmacology, Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology and Hepatology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Salivary Gland Disorders and Functions (5 papers), Statistical Methods in Clinical Trials (4 papers), Hepatitis C virus research (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Peptidase Inhibition and Analysis (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Transplantation (141 citations), Cognitive Neuroscience (402 citations), Virology (54 citations), Radiology, Nuclear Medicine and Imaging (248 citations) and Hepatology (84 citations). Wen‐Lin Luo has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Thomas E. Nichols, Torben E. Lund, Kristoffer H. Madsen, Karam Sidaros, John A. Wagner, Gary Herman, Arthur Bergman, Michael J. Davies, Steven J. Chadban and Hélio Tedesco‐Silva. Their work appears in journals such as NeuroImage, The Journal of Clinical Pharmacology, Pharmaceutical Statistics, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact